Ha. Stirnadel et al., Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea, INT J EPID, 29(3), 2000, pp. 579-586
Citations number
53
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Background A potential problem for malaria vaccine development and testing
is between-host variation in antibody responses to specific malaria antigen
s. Previous work in adults in an area highly endemic for Plasmodium falcipa
rum in Papua New Guinea found that genetic regulation partly explained hete
rogeneity in responsiveness. We have now assessed the relative contribution
s of environmental and genetic factors in total IgG responses to specific m
alaria antigens in children, and quantified temporal variation within indiv
iduals of total IgG responses.
Methods Total IgG responses against schizont extract, merozoite surface pro
tein-1, merozoite surface protein-2, ring-infected erythrocyte surface anti
gen, and SPf66 were measured by ELISA. Variance component analysis was used
to estimate the variation explained by genetic and environmental factors i
n these antibody responses. Intra- and inter-class correlations of antibody
responses within relative pairs were estimated. We adjusted for age, P. fa
lciparum density, sex and village differences either within or prior to the
analysis.
Results For all malaria antigens, temporal variation in the total IgG respo
nse was the predominant source of variation. There was substantial familial
aggregation of all IgG responses, but it remained unclear how much this cl
ustering was attributable to genetic factors and how much to a common envir
onment in the household. The remaining variance, which could not be explain
ed by either of the above, was very small for most of the antigens.
Conclusions Temporal variation and clustering of immune responses to specif
ic malaria antigens need to be taken into account when planning, conducting
and interpreting immuno-epidemiological and vaccine studies.